Picking the right target for HSC-mediated gene therapy
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA433002
下载链接
链接失效反馈官方服务：
资源简介：
Hematopoietic stem cell (HSC)-mediated gene therapy holds enormous potential for the treatment of hematological diseases and disorders. However, most strategies target CD34+ cells, a heterogeneous mix of predominantly committed progenitors and only very few multipotent HSCs. Consequently, the HSC targeting efficiency is low, the long-term outcome poor and currently available approaches very costly.
创建时间：
2018-02-05
